Hostname: page-component-7479d7b7d-wxhwt Total loading time: 0 Render date: 2024-07-10T20:45:24.389Z Has data issue: false hasContentIssue false
  • English
  • Français

It is time to define antimicrobial never events

Published online by Cambridge University Press:  05 December 2018

Jiajun Liu Open the ORCID record for Jiajun Liu [Opens in a new window] ,
Keith S. Kaye Open the ORCID record for Keith S. Kaye [Opens in a new window] ,
Nicholas J. Mercuro ,
Susan L. Davis ,
Twisha S. Patel ,
Lindsay A. Petty ,
Gwendolyn M. Pais Open the ORCID record for Gwendolyn M. Pais [Opens in a new window]  and
Marc H. Scheetz Open the ORCID record for Marc H. Scheetz [Opens in a new window]
Jiajun Liu
Affiliation:
Pharmacometrics Center of Excellence, Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois Northwestern Memorial Hospital, Chicago, Illinois
Keith S. Kaye
Affiliation:
University of Michigan Medical School, Ann Arbor, Michigan
Nicholas J. Mercuro
Affiliation:
Henry Ford Hospital, Detroit, Michigan Eugene Applebaum College of Pharmacy, Wayne State University, Detroit, Michigan
Susan L. Davis
Affiliation:
Henry Ford Hospital, Detroit, Michigan Eugene Applebaum College of Pharmacy, Wayne State University, Detroit, Michigan
Twisha S. Patel
Affiliation:
Michigan Medicine, University of Michigan, Ann Arbor, Michigan
Lindsay A. Petty
Affiliation:
Michigan Medicine, University of Michigan, Ann Arbor, Michigan
Gwendolyn M. Pais
Affiliation:
Pharmacometrics Center of Excellence, Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois
Marc H. Scheetz*
Affiliation:
Pharmacometrics Center of Excellence, Department of Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois Northwestern Memorial Hospital, Chicago, Illinois
*
Author for correspondence: Marc H. Scheetz, PharmD, MSc, Professor of Pharmacy Practice; Midwestern University, Chicago College of Pharmacy, Pharmacometrics Center of Excellence; 555 31st St, Downers Grove, IL 60515. E-mail: mschee@midwestern.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Inappropriate antibiotic use is associated with increased antimicrobial resistance and adverse events that can lead to further downstream patient harm. Preventative strategies must be employed to improve antibiotic use while reducing avoidable harm. We use the term “antibiotic never events” to globally recognize and define the most inappropriate antibiotic use.

Type
Commentary
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 2 , February 2019 , pp. 206 - 207
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Liu J, et al. (2019). It is time to define antimicrobial never events Infection Control & Hospital Epidemiology 2019, 40, 206–207. doi: 10.1017/ice.2018.313

References

1. Llor, C, Bjerrum, L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5:229–241.Google Scholar
2. Antibiotic/Antimicrobial resistance (AR/AMR). Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/index.html. Published 2017. Accessed October 7, 2018.Google Scholar
3. Tamma, PD, Avdic, E, Li, DX, Dzintars, K, Cosgrove, SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:1308–1315.Google Scholar
4. Lode, H. Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections. Am J Med 2010;123(4 Suppl):S26–S38.Google Scholar
5. Agency for Health Care Quality and Research. Patient Safety Primer: Never events. Patient Safety Network website. https://psnet.ahrq.gov/primers/primer/3/Never-Events. Updated August 2018. Accessed November 15, 2018.Google Scholar
6. Brown, J, Doloresco, F III, Mylotte, JM. “Never events”: not every hospital-acquired infection is preventable. Clin Infect Dis 2009;49:743–746.Google Scholar
7. Glowacki, RC, Schwartz, DN, Itokazu, GS, Wisniewski, MF, Kieszkowski, P, Weinstein, RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 2003;37:59–64.Google Scholar
8. Zalmanovici Trestioreanu, , A 1, Lador, , A, Sauerbrun-Cutler, , MT, Leibovici, , L. Antibiotics for asymptomatic bacteriuria. Cochrane Database Syst Rev 2015;4:CD009534.Google Scholar
9. Shiley, KT, Lautenbach, E, Lee, I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol 2010;31:1177–1183.Google Scholar
10. Berger, ER, Greenberg, CC, Bilimoria, KY. Challenges in reducing surgical “never events.” JAMA 2015;314:1386–1387.Google Scholar
11. Milstein, A. Ending extra payment for “never events”—stronger incentives for patients’ safety. N Engl J Med 2009;360:2388–2390.Google Scholar